These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 1756202

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Serotonergic function in obsessive-compulsive disorder. Behavioral and neuroendocrine responses to oral m-chlorophenylpiperazine and fenfluramine in patients and healthy volunteers.
    Hollander E, DeCaria CM, Nitescu A, Gully R, Suckow RF, Cooper TB, Gorman JM, Klein DF, Liebowitz MR.
    Arch Gen Psychiatry; 1992 Jan; 49(1):21-8. PubMed ID: 1728249
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Neuroendocrine effects of M-chlorophenylpiperazine, a serotonin agonist, in humans.
    Mueller EA, Murphy DL, Sunderland T.
    J Clin Endocrinol Metab; 1985 Dec; 61(6):1179-84. PubMed ID: 4055985
    [Abstract] [Full Text] [Related]

  • 9. Effects of alprazolam on increases in hormonal and anxiety levels induced by meta-chlorophenylpiperazine.
    Sevy S, Brown SL, Wetzler S, Kotler M, Molcho A, Plutchik R, van Praag HM.
    Psychiatry Res; 1994 Sep; 53(3):219-29. PubMed ID: 7870844
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Heterogeneity of serotonergic response in treatment-refractory schizophrenia patients.
    Lindenmayer JP, Adityanjee, Vital-Herne M, Bark N, Grochowski S, Moynihan N.
    Biol Psychiatry; 1997 Jul 01; 42(1):6-12. PubMed ID: 9193736
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Acute inositol does not attenuate m-CPP-induced anxiety, mydriasis and endocrine effects in panic disorder.
    Benjamin J, Nemetz H, Fux M, Bleichman I, Agam G.
    J Psychiatr Res; 1997 Jul 01; 31(4):489-95. PubMed ID: 9352475
    [Abstract] [Full Text] [Related]

  • 18. Serotonin function in anxiety. II. Effects of the serotonin agonist MCPP in panic disorder patients and healthy subjects.
    Charney DS, Woods SW, Goodman WK, Heninger GR.
    Psychopharmacology (Berl); 1987 Jul 01; 92(1):14-24. PubMed ID: 3110824
    [Abstract] [Full Text] [Related]

  • 19. Cortisol response during different anxiogenic challenges in panic disorder patients.
    Targum SD.
    Psychoneuroendocrinology; 1992 Oct 01; 17(5):453-8. PubMed ID: 1484913
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.